Sinopec Capital Expands into High-End PLA Degradable Materials through Investment in Hisun Biomaterials

Sinopec Capital Expands into New Energy and New Materials through Investment in PV Film Value Chain

New Opportunities New Advances：Sinopec Capital Annual Forum

Sinopec Capital Investee Company Richful Listed on ChiNext Market

On November 27th, Richful (300910), a Sinopec Capital invested company, was listed on Shenzhen's start-up board ChiNext. Sinopec Capital Chairman Huang Wensheng, Vice Chairman and President Sun Mingrong were present at the bell-ringing ceremony in Shenzhen in celebration of the IPO success.

Sinopec Capital Investee Company SUPCON Listed on STAR Market

Huang Wensheng Speaks at 2020 China-U.A.E. Innovation Investment Conference

Sinopec Capital and Cummins Jointly Promote Green Hydrogen Industrial Development

JV Formed to Support Sinopec High-End Graphite Material Brand

Sinopec Capital & CNPC Capital Hold Joint Workshop

Huang Wensheng Visits Re-Fire

On September 11th, Mr. Huang Wensheng, Vice President and Board Secretary of Sinopec Corporation, President of Sinopec Strategic Business Unit of Capital and Financial Services, Chairman of Sinopec Capital Co., Ltd., visited the R&D center of Re-Fire Headquarters.

Sinopec Capital First Fund Launched

​Launched by Sinopec Capital Co., Ltd., Enze Fund had its business registration completed recently, marking the establishment of the first fund of Sinopec.

Huang Wensheng Visits Legend Capital

Huang Wensheng Visits SK China

Sinopec Capital expands into photovoltaic and photoelectric industry through investment in Fengyang Guigu Intelligence

17th Sinopec Capital Forum

Huang Wensheng visits Beijing Honghui Energy Development Co., Ltd.

Huang Wensheng Visits Zhejiang Hisun Biomaterials

Huang Wensheng Meets DuPont Asia Pacific President

Huang Wensheng Meets Head of Yangpu District of Shanghai

Sinopec Capital Invests in CapitalBio Technology to Support Biological Chip Nucleic Acid Detection against COVID-19

On June 29th, 2020, Sinopec Capital Co., Ltd. announced its investment in CapitalBio Technology Co., Ltd., in a bid to unleash the advantages of CapitalBio in biological chip and support the fast detection test as well as accurate prevention and control against COVID-19.

Sinopec Forging Ahead with Quality Growth in Xiong’an New Area